spacer
home > epc > Winter 2019
PUBLICATIONS

European Pharmaceutical Contractor

epc
Winter 2019

   
Text
PDF
bullet
Clinical data
Precision Medicine Challenges

Realising International Data Access through Data Collaborations

Randy Ramin-Wright and Le Vin Chin at Clinerion explain how gaining access to real-world data on a global scale does not have to be intimidating and can be readily achieved through the use of the latest consolidation technologies.
 
view
download pdf
Data Oversight and Integrity

Improving Quality Using Centralised Statistical Monitoring

With new regulations and the continuing importance of quality management over regulatory submissions, monitoring data integrity and oversight is pivotal to success. Thomas Underwood at Quanticate explains more.
 
view
download pdf
CRO Consolidation and Global Growth

Exploring Growth Strategies for Smaller CROs

The life sciences industry is no stranger to mergers and acquisitions, particularly when discussing midsized CROs. Zac Beda at Upsilon Global examines the practice and looks into the benefits.
 
view
download pdf
   
spacer



Published quarterly in
February, May,
August, and November

News and Press Releases

CPI to showcase results from BioStreamline project developing novel biotherapeutics

CPI, a UK-based technology innovation centre and a founding member of the High Value Manufacturing Catapult, announced today that it will host an event in Darlington, UK on 26 June 2019 to disseminate the results of the £11.2M BioStreamline project to optimise the development of novel therapeutics. During the event, the project partners — Lonza Biologics, UCB Celltech, Sphere Fluidics, Horizon Discovery Group plc (Horizon), Alcyomics Ltd and CPI — will showcase the results and discuss the potential impact on overcoming some of the most significant shortcomings of the biologics supply chain.
More info >>

White Papers

Choosing the Right CMO for HPAPI Manufacturing

AMRI

Over the past few years a steady stream of contract manufacturing organizations (CMO) have added high potency active pharmaceutical ingredient (HPAPI) production capacity. The expansions give biopharma executives charged with selecting HPAPI production partners an unprecedented number of options, but all this choice creates a problem — which CMO should you pick when each is touting similar technical capabilities?
More info >>

Industry Events

The Universe of Pre-filled Syringes and Injection Devices

22-23 October 2019, The Swedish Exhibition & Congress Centre Gothia Towers Hotel

PDA’s Universe of Pre-filled Syringes and Injection Devices has become the must-attend meeting for everyone working in the field, and is now the world’s largest conference on this subject
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement